{"name":"Abion Inc","slug":"abion-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ABN401- Expansion Phase","genericName":"ABN401- Expansion Phase","slug":"abn401-expansion-phase","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ABN401- Expansion Phase","genericName":"ABN401- Expansion Phase","slug":"abn401-expansion-phase","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPQmdCUlY0bVY0c1JxNGZtMGxhcE1GWHRwZHhiWmxoR3hVM1A0SEtwMi1nWnhNOXpXcnRvOFFvR0lvZTZpYkJrREgwT3RvVFMydUNibTBaNXZWUUpLU2NRSERUX3pmN0xKS2dZZlQ3LW5hTE5JVGNUcHVqclNBQk9Ya3BZUVVvVmNEVHB3a0VpSjh6RjVLNDNfcjlPbHQ?oc=5","date":"2025-12-29","type":"pipeline","source":"BioWorld News","summary":"Top issues in South Korea’s biotechnology sector in 2025 - BioWorld News","headline":"Top issues in South Korea’s biotechnology sector in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOYk13ZmlBeG16V1NIQ2JDU1FBVVFZdGVxRmRDWnEtMXpiajRLcEM5N3hpbmdGcnJMcWhXalctMVdfYlFkdDZIeW5YRWx3SGE0ZmNaVEFhVkxwTWs5Z0hCcElib0VJRHJzWXpraG1YeFBXNDRVX0tnMnRPeGM0UmFFU05GLUpqVi1sOWprM0dkMU5zelRzTkx5SXhESjJPM05BVEhNcW1R?oc=5","date":"2025-07-01","type":"deal","source":"BioWorld News","summary":"Abion strikes $1.3B antibody drug deal with unidentified partner - BioWorld News","headline":"Abion strikes $1.3B antibody drug deal with unidentified partner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE04VTNZZ2RyZFJVbDNKdldJLUJzYndSd3pnT0N2ZkxmMlBjV0ozRnFBMjl6eDJVTHJma2JKWnFNUGhQSkFOdURTX3Q5a2tMWE9POWdYSURKUWIwSTZSc2NaYTYtUVFEYWc4SlJDYmdB0gFyQVVfeXFMT1B6ell3ZS1wYXR3eWNhc09CY3RWSFJjMzJzNGl4WTFmZGROdnZuOHNZLW9KOGpSYmxlYklSVldTZURWLThjR19BaGdFZ3p1aENMWUhocFRfd29fclpjVTIzVzRMbzV4czc5NzZxajNNUk5n?oc=5","date":"2025-06-25","type":"deal","source":"koreabiomed.com","summary":"ABION BIO signs $1.3 billion antibody drug licensing deal for CLDN3-targeted cancer therapy - koreabiomed.com","headline":"ABION BIO signs $1.3 billion antibody drug licensing deal for CLDN3-targeted cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNREVXTHB3b2xyVjYxTG1SNlhUU09jUTNkb0htYmlYWmVWYkJ4cHJpWTROYVNIYnE0dzlXYkNWWUpBRVMwN3RIM09TZG5ldXc0dmkzUGR0YmQxYXpTMG5FSmg5aEVUcUU4cDdjVU8wbWJKcVMySVZ4ZnN5eXFMaEthc9IBlAFBVV95cUxNU19CTHhkcnEwT00zVnlqazZHN3FkUHItc2xjYUp3Q05CWlZ5V1JuM1pGNUZtRWIxT2NsLUJzeU1YWmZCVFBGY2ZIN3l6UTFkMDB5ZVF6NEoxcEVEUUczclBZSkllWWlicXJCcm9EQW1XS3U3SW0yYVJPTG9nQWIxbzJVNXhCNGZiOFR2b003N3d6MFhH?oc=5","date":"2025-06-24","type":"pipeline","source":"Chosunbiz","summary":"ABION transfers 1.8 trillion won technology for cancer drug targeting CLDN3 - CHOSUNBIZ - Chosunbiz","headline":"ABION transfers 1.8 trillion won technology for cancer drug targeting CLDN3 - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBOWHlyQ3VQN21qNUx5YzZqUTNRWVd0dmU4c1FPMmYxU015bU4zZFZrb1dfUFZnTnJfeEw1Szg3dnlUc2Y4bnJDVDBONTZtZ1QzZW9wZ0RZSTdzVmZiTDl1VHY2Wi1tUnpQZE1sd3pB?oc=5","date":"2022-12-28","type":"regulatory","source":"KED Global","summary":"Korean biotechs target US labs to speed up regulatory approval for tests - KED Global","headline":"Korean biotechs target US labs to speed up regulatory approval for tests","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}